1.30 Valo Therapeutics Announces Two European Patents Granted for its Lead Asset PeptiCRAd-1 in Immuno-Oncology

News


<< back

Valo Therapeutics Announces Two European Patents Granted for its Lead Asset PeptiCRAd-1 in Immuno-Oncology
Date: 2023-02-16 [news.yahoo.com]

READ THE FULL NEWS >>
×